Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome

By Lanzone A.   Fulghesu A.M.   Guido M.   Cucinelli F.   Caruso A.   Mancuso S.  

Fertility and Sterility, Vol. 67, Iss. 1, 1997-01 ,pp. : 34-39

Elsevier

Access to resources Recommend Favorite

Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome

By Guido M.   Romualdi D.   Mancini A.   Lattanzi F.   Villa P.   Barini A.   Lanzone A.   De Marinis L.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 994-1000

Elsevier

Access to resources Recommend Favorite

Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome

By Cohen D.P.   Stein E.M.   Li Z.   Matulis C.K.   Ehrmann D.A.   Layman L.C.  

Fertility and Sterility, Vol. 72, Iss. 2, 1999-08 ,pp. : 360-363

Elsevier

Access to resources Recommend Favorite

Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials

By Scheele F.   van der Meer M.   Lambalk C.B.   Schoute E.   Schoemaker J.   Hompes P.G.A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 62, Iss. 2, 1995-10 ,pp. : 221-224

Elsevier

Access to resources Recommend Favorite

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess

By Moran C.   Reyna R.   Boots L.S.   Azziz R.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 126-131

Elsevier

Access to resources Recommend Favorite